PharmaCyte Biotech Inc (PMCB) — Cash Flow Quality Index
PharmaCyte Biotech Inc (PMCB) has a Cash Flow Quality Index of -1.05x as of January 2026. Operating cash flow of $-786.85K is below net income of $746.86K, suggesting accrual-heavy earnings not yet converted to cash. Explore PharmaCyte Biotech Inc (PMCB) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaCyte Biotech Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for PharmaCyte Biotech Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PMCB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PharmaCyte Biotech Inc (2024–2025)
Year-by-year earnings quality comparison for PharmaCyte Biotech Inc. For live market cap and the full company financial profile, see market value of PharmaCyte Biotech Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | $-2.98 Million | $30.66 Million | ▲ +98.5% |
| 2024 | -6.45x | $-2.15 Million | $333.76K | — |